{"product_id":"retatrutidert","title":"Retatrutide(RT)","description":"\u003cdiv\u003e\n\u003ch3\u003eWhat Is Retatrutide (RT) Peptide?\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cdiv\u003eIn the evolving landscape of metabolic peptides, Retatrutide (RT) has emerged as a groundbreaking triple-agonist peptide, renowned for its powerful \u003cstrong\u003eglycemic control, appetite regulation, and superior weight management\u003c\/strong\u003e effects by targeting three key metabolic receptors simultaneously. Unlike single or dual-action peptides, Retatrutide delivers comprehensive metabolic support, making it a top choice for those seeking to address obesity, type 2 diabetes, and optimize overall metabolic health. If you’re new to Retatrutide, let’s break down its basics, scientific background, and how it works to transform metabolic wellness.\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\n\u003ch4\u003e1. Basic Information: Full Name, Abbreviation and Molecular Formula\u003c\/h4\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cdiv\u003eRetatrutide is commonly known by its abbreviation \u003cstrong\u003eRT\u003c\/strong\u003e, with the research designation \u003cstrong\u003eLY3437943\u003c\/strong\u003e. It is a \u003cstrong\u003esynthetic 39-amino-acid triple-receptor agonist peptide\u003c\/strong\u003e engineered with a C20 fatty diacid moiety to enhance stability and extend half-life to approximately 6 days, supporting convenient once-weekly administration. Its amino acid sequence is:\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cstrong\u003eTyr-Aib-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-α-Me-Leu-Leu-Asp-Lys-Ala-Gln-Aib-Ala-Phe-Ile-Glu-Tyr-Leu-Leu-Glu-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2\u003c\/strong\u003e.\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\nThe molecular formula is \u003cstrong\u003eC₂₂₁H₃₄₂N₄₆O₆₈\u003c\/strong\u003e, with a molecular weight of approximately \u003cstrong\u003e4731 Da (4.73 kDa)\u003c\/strong\u003e. As a highly stable, lipidated peptide, it is easily synthesized, purified, and formulated for research and wellness applications.\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\n\u003ch4\u003e2. Scientific Research Progress of Retatrutide (RT) Peptide\u003c\/h4\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cdiv\u003eResearch on Retatrutide began with Eli Lilly’s efforts to develop a next-generation metabolic therapy, building on the success of GLP-1 (semaglutide) and dual GLP-1\/GIP (tirzepatide) agonists. Preclinical studies in the 2010s confirmed its unique ability to \u003cstrong\u003esimultaneously activate GLP-1, GIP, and glucagon receptors (Triple G agonism)\u003c\/strong\u003e—a first-in-class mechanism that addresses metabolic dysfunction through three complementary pathways.\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cdiv\u003eInitial Phase 2 clinical trials (2021–2023) in obese and type 2 diabetes patients yielded transformative results: \u003cstrong\u003e48-week treatment with Retatrutide 12 mg achieved up to 24.2% body weight reduction\u003c\/strong\u003e, surpassing semaglutide (~15%) and tirzepatide (~22.5%). In 2026, Phase 3 trial (TRANSCEND-T2D-1) data published in \u003cem\u003eThe Lancet\u003c\/em\u003e validated its efficacy: 40-week treatment reduced HbA1c by up to 2.0% and body weight by \u003cstrong\u003e16.8% (36.6 lbs)\u003c\/strong\u003e in type 2 diabetes patients, with no weight loss plateau observed\u003cspan\u003e\u003c\/span\u003e\u003cspan\u003eEli Lilly ...\u003c\/span\u003e\u003cspan\u003e\u003c\/span\u003e.\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cdiv\u003eRecent research has expanded its potential applications. Preclinical studies in \u003cem\u003ePMC\u003c\/em\u003e journals demonstrate Retatrutide’s ability to \u003cstrong\u003einhibit tumor growth and enhance chemotherapy efficacy in obese triple-negative breast cancer (TNBC)\u003c\/strong\u003e by regulating YAP signaling and glycosylation pathways\u003cspan\u003e\u003c\/span\u003e\u003cspan\u003ePMC\u003c\/span\u003e\u003cspan\u003e\u003c\/span\u003e. Additional studies highlight its benefits for non-alcoholic fatty liver disease (NAFLD), cardiovascular risk reduction, and metabolic syndrome management. While still under FDA review (not yet approved for clinical use), its \u003cstrong\u003efavorable safety profile (mild gastrointestinal side effects: nausea, diarrhea)\u003c\/strong\u003e and unprecedented efficacy have positioned it as the most promising metabolic peptide in late-stage development\u003cspan\u003e\u003c\/span\u003e\u003cspan\u003e柳叶刀Th...\u003c\/span\u003e\u003cspan\u003e\u003c\/span\u003e.\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\n\u003ch4\u003e3. Biological Action Mechanism of Retatrutide (RT) Peptide\u003c\/h4\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cdiv\u003eRetatrutide exerts its powerful metabolic effects through \u003cstrong\u003ethree synergistic receptor pathways\u003c\/strong\u003e, working in harmony to regulate glucose, appetite, and energy expenditure—surpassing the limitations of single\/dual agonists. Its mechanisms are well-documented in preclinical and clinical research:\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eGLP-1 Receptor Activation\u003c\/strong\u003e: Binds to GLP-1 receptors in the pancreas, brain, and gut, driving \u003cstrong\u003eglucose-dependent insulin secretion\u003c\/strong\u003e, suppressing glucagon (high blood sugar hormone), slowing gastric emptying, and reducing appetite via hypothalamic signaling. This core pathway delivers robust glycemic control and initial weight loss.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGIP Receptor Activation\u003c\/strong\u003e: Complementary to GLP-1, GIP receptor activation \u003cstrong\u003eenhances insulin secretion\u003c\/strong\u003e, improves metabolic efficiency, and modulates central hunger signals—amplifying weight loss and glycemic benefits beyond single GLP-1 agonists.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGlucagon Receptor Activation (Key Differentiator)\u003c\/strong\u003e: The unique third pathway that sets Retatrutide apart. It \u003cstrong\u003epromotes hepatic fat oxidation, increases basal metabolic rate (BMR), and elevates energy expenditure\u003c\/strong\u003e, directly reducing liver fat (NAFLD) and driving superior weight loss by burning stored fat—without the hyperglycemic risk, offset by GLP-1 activity.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSynergistic Metabolic Benefits\u003c\/strong\u003e: Combined triple agonism optimizes \u003cstrong\u003ebody composition (reducing fat mass while preserving lean muscle)\u003c\/strong\u003e, improves lipid profiles (lower triglycerides, higher HDL), and reduces inflammation—supporting long-term metabolic health and reducing cardiovascular risk.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cdiv\u003eIn summary, Retatrutide (RT) is a revolutionary, science-backed triple-agonist peptide with a well-defined mechanism of action and robust clinical research foundation. Its unparalleled ability to \u003cstrong\u003econtrol blood sugar, suppress appetite, burn fat, and optimize metabolic health\u003c\/strong\u003e makes it the most advanced peptide for obesity and type 2 diabetes management. With its stable structure, long half-life, high purity, and exceptional efficacy, Retatrutide has become the most sought-after metabolic peptide in the global wellness and research markets.\u003c\/div\u003e\n\u003c\/div\u003e","brand":"xprimepeptide.com","offers":[{"title":"5mg*10vials","offer_id":43294621663309,"sku":null,"price":75.0,"currency_code":"USD","in_stock":true},{"title":"10mg*10vials","offer_id":43294621696077,"sku":null,"price":95.0,"currency_code":"USD","in_stock":true},{"title":"15mg*10vials","offer_id":43294621728845,"sku":null,"price":105.0,"currency_code":"USD","in_stock":true},{"title":"20mg*10vials","offer_id":43294621761613,"sku":null,"price":170.0,"currency_code":"USD","in_stock":true},{"title":"30mg*10vials","offer_id":43294621794381,"sku":null,"price":200.0,"currency_code":"USD","in_stock":true},{"title":"40mg*10vials","offer_id":43294621827149,"sku":null,"price":255.0,"currency_code":"USD","in_stock":true},{"title":"50mg*10vials","offer_id":43294621859917,"sku":null,"price":290.0,"currency_code":"USD","in_stock":true},{"title":"60mg*10vials","offer_id":43294621892685,"sku":null,"price":320.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0689\/5049\/1213\/files\/5_cleanup_3.png?v=1784703076","url":"https:\/\/xprimepeptide.com\/products\/retatrutidert","provider":"xprimepeptide.com","version":"1.0","type":"link"}